UBS’s Balchem Corp BCPC Stock Holding History

UBS’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-100	Closed	-$4K	–	10771
2013 Q2	$4K	Buy	+100	New	+$4.47K	﹤0.01%	9449

Other funds holding BCPC

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

UBS's BCPC Position: Q3 2014 in Review

UBS increased its Balchem Corp (BCPC) stake by 13% in Q3 2014, buying an estimated $60.7K and bringing the position to 9,949 shares worth $563K. The position accounts for ﹤0.01% of the portfolio, ranked #4139.

UBS first reported a position in BCPC in Q2 2013 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold BCPC as of Q3 2014.

UBS held 9,949 shares of Balchem Corp worth $563K as of Q3 2014.
UBS bought 1,140 Balchem Corp shares in Q3 2014, an estimated $60.7K.
Balchem Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4139 holding.
UBS first reported a position in Balchem Corp in Q2 2013 and has held it in 6 quarters since.
161 funds tracked by Wall St. Rank held Balchem Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.